After Hours
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility.
Stocks Info
NVAX belongs to the Healthcare sector of the NASDAQ while operating in the Biotechnology industry. The current market capitalization of Novavax, Inc is $1.11B. A total of 1.99 million shares were traded on the day, compared to an average of 4.04M shares.
In the most recent transaction, YOUNG JAMES F bought 10,000 shares of NVAX for 7.59 per share on May 19 ’25. In a previous transaction on Apr 14 ’25, YOUNG JAMES F bought 4,000 shares at 6.10 per share.
Among the insiders who sold shares, YOUNG JAMES F disposed of 5,400 shares on Dec 31 ’24 at a per-share price of $8.00. This resulted in the Director holding 51,760 shares of NVAX after the transaction.
While price targets are rarely accurate, they tend to exert some kind of influence from time to time and are often taken into account by investors. In terms of 52-week highs and lows, NVAX has a high of $11.55 and a low of $5.01.
As of this writing, NVAX has an earnings estimate of -$0.49 per share for the current quarter. EPS was calculated based on a consensus of 7.0 estimates, with a high estimate of -$0.11 per share and a lower estimate of -$1.36. The company reported an EPS of -$0.52 in the last quarter
Balance Sheet Annually/Quarterly
An organization’s balance sheet depicts the assets and liabilities it has, as well as the amount of equity invested. Investors can measure a company’s prospects by calculating its financial ratios using this information. NVAX’s latest balance sheet shows that the firm has $1.52B in Cash & Short Term Investments as of fiscal 2021. There were $453.99M in debt and $2.39B in liabilities at the time. Its Book Value Per Share was -$0.96, while its Total Shareholder’s Equity was -$351.67M.
Analysts Opinion
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for NVAX is Buy with a score of 3.50.
